, an antibody against Thermus aquaticus DNA polymerase I (TaqP), is used as a thermolabile switch in 'hot start' variations of PCR to minimize non-specific amplification events. Earlier studies have established that TP7 binds to the polymerase domain of TaqP, competes with primer template complex for binding and is a potent inhibitor of the polymerase activity of TaqP. We report crystallographic determination of the structure of an Fab fragment of TP7 and computational docking of the structure with the known three-dimensional structure of the enzyme. Our observations strongly suggest that the origin of inhibitory ability of TP7 is its binding to enzyme residues involved in DNA binding and polymerization mechanism. Although criteria unbiased by extant biochemical data have been used in identification of a putative solution, the resulting complex offers an eminently plausible structural explanation of biochemical observations. The results presented are of general significance for interpretation of docking experiments and in design of small molecular inhibitors of TaqP, that are not structurally similar to substrates, for use in PCR. Structural and functional similarities noted among DNA polymerases, and the fact that several DNA polymerases are pharmacological targets, make discovery of non-substrate based inhibitors of additional importance.
Introduction
Thermus aquaticus DNA polymerase I [TaqP] is a bacterial polymerase that functions at elevated optimal temperatures of 72-74°C (Chien et al., 1976; Lawyer et al., 1989) . Its remarkable thermostability makes TaqP the ideal enzymatic component of PCR (Mullis et al., 1986) , a technique of unquestioned importance in molecular biology, medical diagnostics and forensic research (Wright et al., 1990; Erlich et al., 1991; Decorte et al., 1993) . DNA-and RNA-dependent DNA polymerases share significant sequence similarities, especially in regions that constitute putative substrate binding sites and those involved in the polymerization mechanism (Joyce and Steitz, 1994) . Some nucleic acid polymerases are targets for chemotherapy of cancer and of viral infections (Elion, 1982; Furman, 1986) .
A number of problems that degrade sensitivity and accuracy contribute to non-specificity of PCR and one such serious problem is amplification of low stringency priming events called zero cycle artifacts (ZCA). Approaches called 'hot start' methods, the most recent of which is the use of thermally switchable oligonucleotides (Dang and Jayasena, 1996) or monoclonal antibodies (mAbs), have been used to minimize these artifacts (Kellogg et al., 1994; Sharkey et al., 1994; Daiss et al., 1995; Scalice et al., 1995) . The oligonucleotides and mAbs work by acting as tight binding inhibitors of the polymerase activity of TaqP at PCR mixing temperatures that dissociate by denaturation at the chain extension temperature (Sharkey et al., 1994; Daiss et al., 1995; Scalice et al., 1995; Dang and Jayasena, 1996) . TP7 is one of a group of such mAbs and has the following properties: no DNA, nucleotide or metal binding by the antibody or Fab can be detected; TP7 binds to the polymerase domain with a dissociation constant of~1 nM; binding of the Fab completely abolishes the polymerase activity of TaqP; enzyme precomplexed with primer template complex (PTC) does not bind TP7 and enzyme that has bound the Fab does not bind PTC; TP7 and its Fab fragment bind to other Thermus polymerases tested with lower affinities but do not bind to Escherichia coli pol I or to the Klenow fragment. These properties, collectively, suggest that the Fab binds to a region of TaqP that participates in either DNA binding or in the polymerization mechanism or both; that binding of the Fab is both necessary and sufficient to completely inhibit the polymerase activity of the enzyme; and that enzyme inhibition is being brought about by interactions that are unique to enzymes of Thermus species (Sharkey et al., 1994; Daiss et al., 1995; Scalice et al., 1995) . Structural and computational results we report here offer evidence for identification of the probable region of interaction between TP7 and TaqP.
It has been demonstrated in a number of cases that the complementarity determining regions (CDRs) of antibodies are capable of mimicking the specificity of the entire antibody although with diminished potency. Using molecular design and modeling techniques dramatic increases in potency, starting from the most efficacious CDR region, have been attained (Williams et al., 1989; Taub and Greene, 1992) . It might, therefore, be possible to mimic inhibition of the enzyme brought about by TP7 through selected CDRs. Inhibitors based on CDRs are likely to form a novel structural class that will not bear structural similarity to either the nucleoside triphosphate or PTC substrates of the enzyme. Structurally different inhibitors will be of importance because they will offer the potential for discovery of compounds that can be targeted more selectively towards a particular DNA polymerase than most currently used inhibitors that are based on nucleotides and nucleosides. Smaller inhibitors than Fabs will also be useful in PCR because they will be easier, simpler and less expensive to synthesize. Principles and strategies that are utilized in designing such inhibitors against TaqP are likely to be applicable to other DNA polymerases because of the structural and functional similarities that have been demonstrated to exist across the family (Joyce and Steitz, 1994) .
Materials and methods
Nucleotide sequence of TP7 variable regions was determined by amplifying cDNA using consensus primers derived from framework I and the J region (Orlandi et al., 1989) and cloning the amplified fragments into a plasmid vector as a single chain Fv. Overlapping linear peptides spanning the entire polymerase domain of TaqP (residues 290-832) were obtained commercially from Chiron Mimotopes (Raleigh, NC, USA). A total of 89 peptides, bound to pins (Geysen et al., 1987) , with acetylated N-termini were used in ELISA assays for epitope mapping. Peptides had a uniform length of 15 residues with an offset of six residues. TP7 Fab was prepared and purified using standard techniques (Harlow et al., 1988) and crystallized in hanging drops using 16% PEG 3350 in the wells at pH 9.0 maintained with 100 mM Tris-HCl. A 2 µl aliquot of a 5 mg/ml solution of protein in 20 mM Tris-HCl, pH 8.0 and 0.4% β octyl glucoside was mixed with an equal volume of the well solution and allowed to equilibrate at 20°C. Crystals appeared approximately a day later and continued to grow to a final size of~0.3ϫ0.3ϫ0.02 mm over the next 10 days. Crystals possessed the symmetry of space group P2 1 with a ϭ 36.5, b ϭ 72.7, c ϭ 82.2 Å and β ϭ 98.4°. Diffraction data to 2.2 Å were measured on a SIEMENS X1000 area detector on two crystals and processed with XDS (Kabsch, 1988) to obtain a unique data set. Statistics pertaining to quality of measured data are given in Table I . The structure was determined by molecular replacement with CCP4 (CCP4, 1994) and AMoRe (Navaza, 1994) using 1HIL (Rini et al., 1992) as the search model and diffraction data between 10 and 4 Å. 1HIL was chosen since it belongs to the same subclass (IgG2a) as TP7 and is also an anti-peptide antibody. Using the entire Fab as the probe, a clearly offset rotation peak with a correlation coefficient of 27.2 (next highest at 16.7) was obtained; a translation search using this peak elicited a solution with a correlation coefficient of 37.1 (next highest at 9.2) and a crystallographic R-value of 0.462 which dropped to 0.422 on rigid body refinement using XPLOR (Brünger et al., 1987) . Although more sophisticated approaches to molecular replacement solutions for antibodies do exist (Leahy (Jones et al., 1991) . Coordinate refinement in XPLOR using standard protocols (Brünger et al., 1990) and all data to 2.2 Å in stages, interspersed with model building, resulted in an R-value of 0.221. The final R-value of 0.196 was obtained on restrained refinement of isotropic B-factors. Concomitant reduction in free R-value was obtained with the final value being 0.288. Distribution of R-value as a function of resolution is given in Table I . All computations were carried out on a Silicon Graphics Power Challenge at the University of Pennsylvania and a Cray YMP at the Frederick Biomedical Supercomputing Center. Refinement statistics and parameters describing the quality of the model, obtained using PRO-CHECK (Laskowski et al., 1993) are given in Table II . Docking calculations were carried out using the refined coordinates for TP7 Fab and coordinates (Korolev et al., 1995) of the klentaq1 (KT) polymerase domain, shown in Figure 1 . The ESCHER [evaluation of surface complementarity, hydrogen-bonding and electrostatic interactions in molecular recognition] computer program (Ausiello et al., 1997) was used for docking calculations. A detailed description of the algorithm, its capabilities, limitations and performance on test problems have been reported (Ausiello et al., 1997) . The algorithm employed in ESCHER is broadly similar to that used in PUZZLE (Helmer-Citterich and Tramontano, 1994) with significant enhancements. To reduce the amount of computation in ESCHER calculations, only the variable domain of the Fab, consisting of residues 1-110 from both light and heavy chains, was used in the docking simulation. Only atoms on the surfaces of the two proteins, as determined by calculation of solvent accessible surfaces at 10 dots/Å 2 density and a 1.8 Å probe sphere (Connolly, 1983) , were utilized. Two orthogonal orientations of TP7 were used to compensate for poor description of protein poles by ESCHER. The two sets of 500 solutions were Kim et al. (1995) . Fingers, palm, thumb and N-term subdomains are labeled. C-and N-termini are indicated. A break in the chain between helices Ha and Hb due to disorder is also visible near the top of the thumb subdomain. Side chains of residues that are contacted by TP7 Fab in the docked complex are shown as balls and sticks; for emphasis these are on a slightly larger scale than the rest of the figure. Helices and strands that are close to residues that contact TP7 Fab are labeled. The figure was composed using MOLSCRIPT (Kraulis, 1991). reduced to a unique set of 620 by grouping together all solutions that differed by an r.m.s. deviation of less than 2.5 Å.
Results and discussion

Structure of TP7 Fab
The overall structure of TP7 is similar to that of other Fabs (Suh et al., 1986) . There are a total of five well defined cis prolines in the structure, one in the light and four in the heavy chain. The binding region has a large cleft in the middle of the pocket similar to the galactan binding Fab, J539 (Suh et al., 1986) . The L1, L2, H1 and H2 CDR loops conform to their respective canonical structures (Chothia et al., 1989) . Figure 2 shows a representative section of a 2Fo-Fc map with the current model for residues H96 to H102 superimposed. This section of the heavy chain forms part of CDR H3 which is the CDR that demonstrates the greatest conformational variation among different antibodies (Wilson and Stanfield, 1994) ; a number of stabilizing interactions with KT are also made by this CDR in the docked complex. Electron density for residues H134 to H137 is ill defined and these residues in the constant regions have been modeled to be in their most probable conformations. The antigen binding region is predominantly populated by hydrophobic residues, resembling, in this aspect, binding regions of antibodies that are specific to carbohydrates and DNA (Suh et al., 1986) . There are no significant departures in hydrogen bonding pattern of the buried parts of the structure from that of other Fabs.
Evaluation of docked complexes
Each of the 620 unique solutions output by ESCHER was externally scored using simple contact criteria expected to be 81 applicable to all Fab-antigen complexes. The six CDRs in TP7 were defined as L1 ϭ 24-34, L2 ϭ 50-56, L3 ϭ 88-96, H1 ϭ 31-35, H2 ϭ 50-65, H3 ϭ 95-102 based on a current classification (Kabat et al., 1991) . A set of coordinates that excluded all atoms of the CDRs of TP7 was generated. All inter-atomic contacts between atoms of TP7 Fab without the CDRs and those of KT in each of the 620 unique solutions were calculated using the program CONTACTS in the CCP4 package (CCP4, 1994) . Those contacts between atoms not expected to be hydrogen bonded were counted as unacceptable if they were less than 2.7 Å (Ramachandran and Sasisekharan, 1968) . Similarly, contacts between atoms expected to be hydrogen bonded were considered unacceptable if they were less than 2.4 Å (Ramachandran and Sasisekharan, 1968) . This calculation identified all unacceptably close contacts that KT, in each orientation, made with the framework and constant portion of the Fab. Figure 3 plots the number of such contacts made by KT in each orientation against the solution number. Since all the inter-atomic interactions in an antigen-antibody complex occur between the CDRs of the antibody (except for participation of a small number of framework residues) and the antigenic epitopes of the antigen, those solutions in which KT makes too many short contacts with the non CDR residues of TP7, in the absence of substantial conformational changes, are unlikely to be correct. Although docking programs such as ESCHER allow limited surface penetration leading to close contacts, these will be limited to the interface between interacting components. Observation of large numbers of bad contacts between framework residues and KT, therefore, implies that a substantial fraction of the interaction interface is contributed by the framework and constant regions, contrary to extant evidence for antigen-antibody interactions (Wilson and Stanfield, 1994) . The solution that generated the smallest number of bad contacts was solution 159 with 13 bad contacts in the constant and framework regions; none of these contacts had a mainchain atom as either partner. The next best solution had 20 times as many bad contacts, as shown in Figure 3 , with a substantial fraction of these involving main chain atoms. A finer search around solution 159, Ϯ15°in angles, at 1°i ntervals, was then carried out and reduced the number of bad contacts to three. Not making a large number of unacceptable contacts in the framework and constant regions is a necessary, but not in itself a sufficient, condition for a plausible complex; stabilizing interactions of the CDRs with the probe must also exist. A calculation of distances between KT residues in the solution and the CDR regions of TP7 revealed that stabilizing (Sheriff et al., 1987) van der Waals interactions with five of six CDR regions were, indeed, made. The fine search solution was then subjected to rigid body refinement and energy minimization using XPLOR to remove all short contacts, resulting in an r.m.s. deviation of 1.5 Å for all atoms in the interface from initial positions. A space filling picture of the CDR regions of TP7 and the interacting region of KT, calculated using the refined coordinates, is shown in Figure 4 and illustrates the surface complementarity.
Description of the complex
Stabilizing inter-residue contacts in the refined model of the complex are summarized in Table III . An expanded view of interactions between CDRs H2 and H3 is also shown in Figure  5 . Comparison of surface area buried on formation of the Fabantigen complex, in a number of cases, has established that not all CDRs contribute equally to the stabilization of the Fig. 2 . Representative section of electron density map for TP7 Fab. A 2Fo-Fc map contoured at 1.0 σ is shown. The atomic model for residues 96-102 in the heavy chain is superimposed; this segment forms part of the H3 CDR. The map was calculated at 2.2 Å using phases from the refined model. The figure was produced using SETOR (Evans, 1993) . The figure is presented as a three-component stereo image. The central component is a right eye image and is flanked by two left eye images. complex (MacCallum et al., 1996) . Analysis of known antigen-antibody structures reveals that CDRs H3 (29%), H2 (23%) and L3 (21%) contribute more buried surface area than CDRs H1 (10%), L1 (9%) and L2 (4%) in an Fab-antigen complex (Wilson and Stanfield, 1994) . Therefore, lack of interactions between L1 of TP7 and KT is not unexpected. While detailed prediction of interaction geometry from structures of two separated components is a difficult problem (Helmer-Citterich and Tramontano, 1994), we have used ESCHER for the more limited purpose of antigenic region identification using surface complementarity and acceptable atomic contacts; no detailed modeling has been attempted since conformational changes on complexation in both antigen and antibody are possible. Conformational changes observed vary from little or no change, as in case of several lysozymeanti lysozyme Fab complexes, to very substantial movements of both sidechain and mainchain atoms resulting in complexes formed by induced fit (Wilson and Stanfield, 1994) . Nevertheless, results obtained from docking calculations are relevant because shapes of extended binding sites in Fabs are not (Nicholls et al., 1991). randomized by conformational changes on formation of the complex. There is little or no change in canonical conformations of five of the six CDR loops on going from the unliganded to the liganded state; most of the substantial changes are confined to CDR H3 (Wilson and Stanfield, 1994) . In the particular instance of KT-TP7 Fab complex, five of the six CDRs make contacts with the antigen and the interactions made by CDRs other than H3 might be relevant in a real complex. In some cases (Bhat et al., 1994) , water molecules have been observed to mediate stabilizing contacts between the antigen and antibody. Not having an ordered solvent model for TP7 undoubtedly prevents water mediated contacts from being detected by the docking algorithm. However, although water a Subset of residues that actually make the contacts (paratope) are in parentheses. b Residues that have been reported to contact the template strand of DNA are shown in bold type. Residues contacted by TP7 that are within two residues of those contacted by the primer strand are shown in italic type and underlined. Note that residues T539 and S575 are common to both classes. Table III . All residues shown make van der Waals contact with the Fab. Those colored red (bold in Table III ) interact with the template strand of the DNA substrate (Eom et al., 1996) , those colored brown do not directly contact DNA and those colored yellow (underlined in Table III ) contact the primer strand. Contacts made by the other CDRs are behind the plane of the figure.
Only selected residues are labeled for clarity. Numbers for residues in the Fab are preceded by an 'H'. The figure was produced using GRASP (Nicholls et al., 1991) .
molecules do make a small number of critical interactions, the dominant contribution to the stability of the complex is made by protein-protein contacts (Wilson and Stanfield, 1994) . A total of 124 van der Waals contacts (Sheriff et al., 1987) stabilize the complex, with 33 residues from the antigen and 24 residues from the antibody participating. There are 19 hydrogen bonds and a single salt link, between E400 of KT and K63 in CDR H2. A comparison between neuraminidase 83 NC41ϩFab (Colman et al., 1987) , one of the largest antigenFab complexes in the Protein Data Bank (Bernstein et al., 1977) , and TP7ϩKT Fab reveals a substantially larger buried surface in the latter (3202 Å 2 ) than in the former (1765 Å 2 ). There might be several explanations for the larger buried surface area in the TP7ϩKT complex. A larger number of residues, 33 are involved in KT compared with 24 in NC41; the TP7 binding surface is shallower permitting recognition of a larger surface on KT; since ESCHER permits some penetration of interacting surfaces, there may be an artifactual component to the buried surface area; alternatively, or in addition, there might, in a real complex, be substantial conformational changes leading to alterations in total buried surface area; or some combination of these circumstances.
Residues contacted in KT by TP7 Fab are shown in Figure  1 . It is seen that the overall antigenic determinant recognized by TP7 Fab is a three-dimensional assembly of components drawn from the palm, thumb and N-term subdomains of TaqP (Kim et al., 1995; Korolev et al., 1995) . The 33 residues of the epitope are made up of 12 from the N-term, 13 residues from the thumb and seven from the palm.
Contacts made with the N-term domain of TaqP include the segment (residues 311-315) at the terminus of strand 1 (Kim et al., 1995) and the loop between strands 1 and 2; in addition, two 3 residue stretches, 385-387 in the loop between helices D and E and 398-400 in the loop between helices E and F along with residue 405 in helix F, are recognized in the Nterm domain. In the thumb, a five residue epitope (residues 542-546) that is located at the terminus of helix I, along with residues 535, 539 and 548 closer to the middle of helix I, and residue 485 in the loop between helices H and Ha, are contacted by TP7 Fab. In the palm subdomain, residues 565 and 568 in strand 7 are contacted as well as a six residue stretch consisting of residues 575-580, which forms the terminal half of strand 8 and the loop between strand 8 and helix J, and residue 580 in the small helix J itself are contacted by the Fab.
Correlation with biochemical data
The three dimensional structures of several nucleic acid polymerases, including that of TaqP, have been determined (Kim et al., 1995; Korolev et al., 1995) . Although direct and detailed mechanistic studies on TaqP are less numerous than they are for KF, TaqP is thought to conform closely to the model developed for E.coli polymerase except for lack of editing features (Lawyer et al., 1989) . Studies that have been carried out on several DNA-and RNA-dependent DNA polymerases, including TaqP, have led to considerable insights into the mechanism of the polymerization process (Joyce and Steitz, 1994) . Due to the structural and sequence similarities that exist across the family of DNA polymerases, it has been suggested that all nucleic acid polymerases are likely to function by very similar mechanisms (Joyce and Steitz, 1994) . Residues used by the enzymes in binding and stabilizing the PTC in a large DNA binding cleft have been shown to be extremely conserved (Joyce and Steitz, 1994) . It has also been shown that parts of the enzyme, most notably the thumb region, undergo substantial movements to enable the enzyme to appropriately position residues required for interaction with DNA (Joyce and Steitz, 1994; Eom et al., 1996) . A recently reported (Eom et al., 1996) structure of TaqP complexed with a 16mer DNA mimicking a PTC, thought to represent a polymerization complex, identifies residues in TaqP that contact DNA. It can be seen from Table III , that some of the residues that are involved in interacting with the template strand of DNA are precisely those with which residues from CDRs of TP7 make van der Waals contact in the docked complex. The residues T539, S543, S575 and N583 in TaqP, that make direct hydrogen bonds with DNA phosphate oxygens (Eom et al., 1996) are also contacted by TP7 in the docked complex. In the docked complex, Y52A of CDR H2 forms a potential H-bond with ND2 of N580 (O...N 2.98 Å) and D31A of CDR H1 forms a potential H-bond with ND2 of N583 (O...N, 3.03 Å); both N580 and N583 are ligands to DNA in the cocrystal complex (Eom et al., 1996) . None of the residues in TaqP involved in interacting with the primer strand are contacted by the TP7 in the docked complex; however, residues close to those that participate in binding and stabilizing the primer strand do, as indicated in Table III , make contact with CDRs of TP7. The C-terminus of the helix I (Figure 1) forms the pivot for large movements of the N-terminus (Joyce and Steitz, 1994; Eom et al., 1996) , needed to form a stable DNA complex and binding by TP7 to several residues in the region 485-568 is very likely to interfere with the required motion. The non-nucleotide inhibitor Nevirapine binds to HIV RT through residues 180-186, in between the β strands of palm and helices of thumb (Kohlstaedt et al., 1992) , in the generally analogous area that TP7 interacts with palm and thumb segments of KT. One of the ways that Nevirapine is thought to act is by restriction of motion of the thumb, the 'sand in gears' hypothesis (Kohlstaedt et al., 1992) .
It is unlikely that recognition of TaqP by TP7 is due to its CDRs mimicking the charge pattern or geometry of the DNA substrate. If that were the case, since DNA polymerases are non-specific DNA-binding proteins and residues that interact with DNA are extremely conserved among them, one might expect the antibody to bind to other DNA polymerases such as E.coli pol I. No detectable binding of TP7 to E.coli DNA polymerase has been observed Scalice et al., 1995) . Since TP7 does bind to other polymerases from Thermus species, it is more likely that a group of residues, some of which participate in DNA binding, that is unique to Thermus polymerases is being recognized by TP7. The docking results, taken together with solution state data on competition between PTC and TP7 for binding to TaqP, imply that the likely mode of inhibition of TaqP by TP7 is either by direct interaction with residues needed by TaqP for binding to the PTC, or by restriction of movements of the thumb region needed to form a stable complex with PTC, or both.
Interactions that TP7 makes with the N-term subdomain would, in part, explain the inability of TP7 to bind and inhibit KF or E.coli pol I. Table IV shows the differences in amino acid sequence between TaqP and KF in the N-term, thumb and palm subdomains. There are no identical residues between the two proteins in the N-term region shown, and in the thumb/palm region, although the majority of residues are identical, there are significant differences. Thus discrimination between TaqP and other polymerases by TP7 is likely a result of a combination of these differences. Other Thermus polymerases show much more sequence similarity (Sullivan, M., unpublished) recognized by TP7 on TaqP is a complex assembled epitope made up of several spatially contiguous linear segments that are distant in amino acid sequence. The difficulty of mimicking assembled epitopes through their linear components is well known and documented (Laver et al., 1990; Tainer et al., 1991) . Several epitope mapping strategies such as PEPSCAN (Geysen et al., 1987) , mutagenesis of putative antigenic regions and display of peptides on bacteriophages (Luzzago et al., 1993) have been used with varying success. In the present case, a set of ELISA experiments, similar to the PEPSCAN procedure, carried out with overlapping peptide sequences covering all of the polymerase domain, designed to systematically sample every six residue epitope did not identify any consistent peptide antigen. The results hint that the epitope recognized by TP7 is an assembled epitope, which constitute 80-95% of all antigenic epitopes on proteins (Benjamin et al., 1984) , but do not identify any specific region of TaqP. However, the combination of facts that no other epitope was identified within the top 620 solutions, the minimally biased character of criteria used to select the solutions and the strong concordance of properties of the chosen solution with experimental data make the present interpretation highly probable. Structural studies that we have begun on co-crystals of a TP7-TaqP complex that have recently been obtained are potentially capable of resolving this question. One of the primary implications of the results presented here is that the region between the thumb and palm subdomains of DNA polymerases might, in general, be a particularly sensitive region for inhibition by inhibitors that are not based on structural similarity to substrates. Several antibodies, including TP7, are used as thermolabile switches in PCR experiments to enhance accuracy. More accurate detection by reducing the background of non-specific products will enable identification of significantly smaller quantities of DNA of infecting organisms.
Results reported here can materially assist in development of small molecular inhibitors based on the CDRs of TP7. Indeed, preliminary results obtained in one of our laboratories (Sharkey et al., unpublished) , suggest a small, but detectable, level of inhibition can be obtained using linear peptides based on CDR regions of TP7 and related antibodies. Linear peptides, due to lack of conformational rigidity are unlikely to be good mimics and efforts to make them more rigid are underway.
In addition, identification and development of inhibitors that are not substrate mimics against enzyme targets is important because, in general, inhibition brought about by molecules that are not substrate analogues permits narrower targeting. For instance, several DNA polymerases are chemotherapeutic targets in treatment of AIDS, cancer, hepatitis and herpes. Most compounds that are used as drugs to target these enzymes are not specific because they are substrate analogues and, as such, inhibit all DNA polymerases, including those of the host, to varying extents (Elion, 1982; Furman, 1986; Kohlstaedt et al., 1992) . Recent reports, however indicate that selectivity can be achieved by capped oligonucleotides (Dang and Jayasena, 1996) although the structural basis of the selectivity is yet to be determined. Searches for non-nucleotide inhibitors have thus been carried out and successes, such as those in case of Nevirapine (Kohlstaedt et al., 1992) , have been obtained. Our current observations provide evidence that it might be possible to obtain results similar to that of inhibition of HIV-RT by Nevirapine by using suitably directed monoclonal antibodies against susceptible regions. Since such susceptible regions are likely to exist in all polymerases due to shared structural and mechanistic similarities, use of monoclonal antibodies might provide a general mode of inhibition of polymerases. Despite similarities in threedimensional structure and polymerization dynamics, differences in sequence in these regions, shown for TaqP-KF pair in Table IV , also exist. Monoclonal antibodies would therefore be targetable to specific polymerases due to detailed differences in sequences of targeted areas. Although by no means a routine exercise, several successes in mimicking the action of antibodies by CDRs have been obtained (Orlandi et al., 1989; Williams et al., 1989; Taub and Greene, 1992) . It might thus be possible to use CDRs of such well characterized Fabs as TP7 as starting points in a search for small molecular mimics. Further, it might be possible to design inhibitors that do not cross react with other DNA polymerases by utilizing structural information from ongoing co-crystallization experiments of TaqP with promising CDR based inhibitors and molecular design techniques (Kuntz, 1992) . It must be pointed out that TaqP is not itself a pharmacological target. But the information gathered on TaqP will be useful in independent studies on pharmacologically more relevant DNA polymerases. Crossreacting monoclonal antibodies raised against peptides from susceptible regions of pharmacologically relevant DNA polymerases might provide good starting points in a search for such inhibitors.
